Cargando…
Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
BACKGROUND: COVID-19 pandemic continues, clarifying signatures in clinical characters and antibody responses between severe and non-severe COVID-19 cases would benefit the prognosis and treatment. METHODS: In this study, 119 serum samples from 37 severe or non-severe COVID-19 patients from the First...
Autores principales: | Wang, Hongye, Yan, Dongshan, Li, Ya, Gong, Yanfei, Mai, Yulin, Li, Bingxiang, Zhu, Xiaoyong, Wan, Xinrui, Xie, Liyun, Jiang, HuaKe, Zhang, Min, Sun, Ming, Yao, Yufeng, Zhu, Yongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809634/ https://www.ncbi.nlm.nih.gov/pubmed/35109926 http://dx.doi.org/10.1186/s40249-022-00940-w |
Ejemplares similares
-
S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants
por: Wang, Hongye, et al.
Publicado: (2023) -
Cytokine Signature Associated With Disease Severity in COVID-19
por: Guo, Jing, et al.
Publicado: (2021) -
Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves’ orbitopathy
por: Shen, Liyun, et al.
Publicado: (2022) -
The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease
por: Li, Ya, et al.
Publicado: (2023) -
Analysis and prediction of the incidence and prevalence trends of gonorrhea in China
por: Chen, Xueya, et al.
Publicado: (2023)